Determination of the potency of remifentanil compared with alfentanil using ventilatory depression as the measure of opioid effect

Anesthesiology

Volumn 90, Issue 6, 1999, Pages 1556-1563

  Glass, Peter S A ^a   Iselin Chaves, Irène A ^a   Goodman, David ^a   Delong, Elizabeth ^a   Hermann, David J ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

Analgesics; Computers; Pharmacodynamics; Pharmacokinetics

Indexed keywords

ALFENTANIL; CARBON DIOXIDE; REMIFENTANIL;

ADULT; ARTICLE; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG POTENCY; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATION DEPRESSION;

ADOLESCENT; ADULT; ALFENTANIL; ANALGESICS, OPIOID; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; HUMANS; MALE; PIPERIDINES; RESPIRATION;

EID: 0032984430     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199906000-00010     Document Type: Article

References (34)

1. James MK, Feldman PL, Schuster SV, Bilotta JM, Brackeen MF, Leighton HJ: Opioid receptor activity of GI87084B, a novel ultra-short acting analgesic, in isolated tissues. J Pharmacol Exp Ther 1991; 259: 712-8
2. Westmorland CL, Hoke JF, Sebel PS, Hug Jr CC, Muir KT: Pharmacokinetics of Remifentanil (GI87084B) and its major metabolite (GI90291) in patients undergoing elective inpatient surgery. ANESTHESIOLOGY 1993; 79:893-903
3. Egan TD, Lemmens HJM, Fiset P, Hermann DJ, Muir KT, Stanski DR, Shafer SL: The pharmacokinetics of the new short-acting opioid remifentanil (GI87084B) in healthy adult male volunteers. ANESTHESIOLOGY 1993;79:881-92
4. Glass PSA, Hardman D, Kamiyama Y, Quill TJ, Marton G, Donn KH, Grosse CM, Hermann D: Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid: Remifentanil (GI87084B). Anesth Analg 1993; 77:1031-40
5. Glass PSA: Remifentanil: A new opioid. J Clin Anesth 1995; 7:558-63
6. Eger EI, Saidman LJ, Brandstater B: Minimum alveolar anesthetic concentration: A standard of anesthetic potency. ANESTHESIOLOGY 1965; 26:756-63
7. Beecher HK: The measurement of pain: Prototype for the quantitative study of subjective responses. Pharmacol Rev 1957; 9:59-209
8. Glass PSA, Shafer SL, Jacobs JR, Reves JG: Intravenous drug delivery systems, Anesthesia, 4th Edition. Edited by Miller RD. New York, Churchill Livingstone, 1994, pp 389-416
9. Afifi MS, Glass PSA, Cohen NA, Shook JE, Camporesi EM: Depression of ventilatory responses to hypoxia and hypercapnia after pentamorphone. Anesth Analg 1990; 71:377-83
10. Glass PSA, Jacobs JR, Smith LR, Ginsberg B, Quill TJ, Bai SA, Reves JG: Pharmacokinetic model-driven infusion of fentanyl: Assessment of accuracy. ANESTHESIOLOGY 1990; 73:1082-90
11. Scott JC, Stanski DR: Decreased fentanyl and alfentanil dose requirements with age. A simultaneous pharmacokinetic and pharmacodynamic evaluation. J Pharmacol Exp Ther 1987; 240:159-66
12. Lambersten CJ, Wendel H: An alveolar pCO2 control system: Its use to magnify respiratory depression by meperidine. J Appl Physiol 1960; 15:43-8
13. Downes JJ, Kemp RA, Lambersten CJ: The magnitude and duration of respiratory depression due to fentanyl and meperidine in man. J Pharmacol Exp Ther 1967; 158:416-20
14. Scott JC, Ponganis KV, Stanski DR: EEG quantitation of narcotic effect: The comparative pharmacodynamics of fentanyl and alfentanil. ANESTHESIOLOGY 1985; 62:234-41
15. Kapila A, Glass PSA, Jacobs JR, Muir KT, Hermann DJ, Shiraishi M, Howell S, Smith RL: Measured context-sensitive half-time of remifentanil and alfentanil. ANESTHESIOLOGY 1995; 83:968-75
16. Grosse CM, Davis IM, Arrendal RF, Jersey J, Amin J: Determination of remifentanil in human blood by liquid-liquid extraction and capillary GC-HRMS-SIM using deuterated internal standard. J Pharm Biomed Anal 1994; 12:195-203
17. Michiels M, Hendriks R, Heykants J: Radioimmunoassay of the new opiate analgesics alfentanil and sufentanil: Preliminary pharmacokinetic profile in man. J Pharm Pharmacol 1983; 35:86-93
18. Holford NHG, Scheiner LB: Understanding the dose-effect relationship: Clinical application of pharmacokinetic-pharmacodynamic models. Clin Pharmacokinet 1981; 6:429-53
19. Egan TD, Minto ChF, Hermann DJ, Barr J, Muir KT, Shafer SL: Remifentanil versus Alfentanil: Comparative pharmacokinetics and pharmacodynamics in healthy adult male volunteers. ANESTHESIOLOGY 1996; 84:821-33
20. Ha H, Wu RS, Contreras RA, Tan EC: Measurement of pain threshold by electrical stimulation of tooth pulp afferents in the monkey. Exp Neurol 1978; 61:260-9
21. Smith GM, Egbert LD, Markowitz RA, Mosteller F, Beecher HK: An experimental pain method sensitive to morphine in man: The submaximal effort tourniquet technique. J Pharmacol Exp Thcr 1966; 154:324-32
22. Handwerker HO: Assessment of experimentally induced pain: Old and new methods. Am J Med 1983; 75:15-8
23. Grossi P, Arnér S: Effect of epidural morphine on the Hoffman-reflex in man. Acta Anaethesiol Scand 1984; 28:152-4
24. Rosenblatt WH, Silvermann DG: PCA as an investigative tool, Acute Pain: Mechanisms and Management. Edited by Sinatra S, Hord AH, Ginsberg B, Preble LH. St. Louis, Mosby-Year Book, 1992, pp 194-200
25. Lehmann KA, Gerhard A, Horrichs-Haermeyer G, Grond S, Zech D: Postoperative patient-controlled analgesia with sufentanil: Analgesic efficacy and minimum effective concentrations. Acta Anaesthesiol Scand 1991; 35:221-6
26. Scott JC, Cooke JE, Stanski DR: Electroencephalographic quantitation of opioid effect: Comparative pharmacodynamics of fentanyl and sufentanil. ANESTHESIOLOGY 1991; 74:34-42
27. Gambus PL, Gregg KM, Shafer SL: Validation of the alfentanil canonical univariate parameter as a measure of opioid effect on the electroencephalogram. ANESTHESIOLOGY 1995; 83:47-56
28. Ausems ME, Hug Jr CC, Stanski DR, Burm AGL: Plasma concentrations of alfentanil required to supplement nitrous oxide anesthesia for general surgery. ANESTHESIOLOGY 1986; 65:362-73
29. Ausems ME, Vuyk J, Hug Jr CC, Stanski DR: Comparison of a computer-assisted infusion versus intermittent bolus administration of alfentanil as a supplement to nitrous oxide for lower abdominal surgery. ANESTHESIOLOGY 1988; 68:851-61
30. Randel GI, Fragen RJ, Librojo ES, Jamerson BD, Gupta S: Remifentanil blood concentration effect relationship at intubation and skin incision in surgical patients compared to alfentanil. ANESTHESIOLOGY 1994; 81:A375
31. McEwan AI, Smith C, Dyar O, Goodman D, Smith LR, Glass PSA: Isoflurane minimum alveolar concentration reduction by fentanyl. ANESTHESIOLOGY 1993; 78:864-9
32. Westmoreland CL, Sebel PS, Gropper A: Fentanyl or alfentanil decreases minimum alveolar anesthetic concentration of isoflurane in surgical patients. Anesth Analg 1994; 78:23-8
33. Brunner MD, Braithwaite P, Jhaveri R, McEwan AI, Goodman DK, Smith LR, Glass PSA: MAC reduction of isoflurane by sufentanil. Br J Anaesth 1994; 72:42-6
34. Lang E, Kapila A, Shlugman D, Hoke JF, Sebel PS, Glass PSA: Reduction of isoflurane minimal alveolar concentration by remifentanil. ANESTHESIOLOGY 1996; 85:721-8